Comparably, HDAC2 inhibitors were also shown to block the transcription of immune checkpoint genes mediated by nuclear translocation of PD-L1, causing increased infiltration of CD8+ cytotoxic T cells in HCC (170). Here, HDAC2 is linked to hepatocellular carcinoma.